299 related articles for article (PubMed ID: 28156048)
41. Patient-derived sialyl-Tn-positive invasive bladder cancer xenografts in nude mice: an exploratory model study.
Bernardo C; Costa C; Amaro T; Gonçalves M; Lopes P; Freitas R; Gärtner F; Amado F; Ferreira JA; Santos L
Anticancer Res; 2014 Feb; 34(2):735-44. PubMed ID: 24511007
[TBL] [Abstract][Full Text] [Related]
42. Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities.
Wessels HJCT; Kulkarni P; van Dael M; Suppers A; Willems E; Zijlstra F; Kragt E; Gloerich J; Schmit PO; Pengelley S; Marx K; van Gool AJ; Lefeber DJ
J Adv Res; 2024 Jul; 61():179-192. PubMed ID: 37683725
[TBL] [Abstract][Full Text] [Related]
43. Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder.
Miyamoto H; Yao JL; Chaux A; Zheng Y; Hsu I; Izumi K; Chang C; Messing EM; Netto GJ; Yeh S
BJU Int; 2012 Jun; 109(11):1716-26. PubMed ID: 22221549
[TBL] [Abstract][Full Text] [Related]
44. Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parameters.
Eltze E; Wild PJ; Wülfing C; Zwarthoff EC; Burger M; Stoehr R; Korsching E; Hartmann A
Eur Urol; 2009 Nov; 56(5):837-45. PubMed ID: 18945538
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.
Youssef R; Kapur P; Shariat SF; Arendt T; Kabbani W; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y
BJU Int; 2012 Oct; 110(7):961-6. PubMed ID: 22372762
[TBL] [Abstract][Full Text] [Related]
46. A Pasteurella multocida sialyltransferase displaying dual trans-sialidase activities for production of 3'-sialyl and 6'-sialyl glycans.
Guo Y; Jers C; Meyer AS; Arnous A; Li H; Kirpekar F; Mikkelsen JD
J Biotechnol; 2014 Jan; 170():60-7. PubMed ID: 24291191
[TBL] [Abstract][Full Text] [Related]
47. Comparison and optimization of strategies for a more profound profiling of the sialylated N-glycoproteomics in human plasma using metal oxide enrichment.
Zhao X; Ma C; Han H; Jiang J; Tian F; Wang J; Ying W; Qian X
Anal Bioanal Chem; 2013 Jun; 405(16):5519-29. PubMed ID: 23620372
[TBL] [Abstract][Full Text] [Related]
48. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation.
Sethi MK; Kim H; Park CK; Baker MS; Paik YK; Packer NH; Hancock WS; Fanayan S; Thaysen-Andersen M
Glycobiology; 2015 Oct; 25(10):1064-78. PubMed ID: 26085185
[TBL] [Abstract][Full Text] [Related]
49. Mapping of truncated O-glycans in cancers of epithelial and non-epithelial origin.
Rømer TB; Aasted MKM; Dabelsteen S; Groen A; Schnabel J; Tan E; Pedersen JW; Haue AD; Wandall HH
Br J Cancer; 2021 Oct; 125(9):1239-1250. PubMed ID: 34526666
[TBL] [Abstract][Full Text] [Related]
50. Sialylation of Thomsen-Friedenreich antigen is a noninvasive blood-based biomarker for GNE myopathy.
Leoyklang P; Malicdan MC; Yardeni T; Celeste F; Ciccone C; Li X; Jiang R; Gahl WA; Carrillo-Carrasco N; He M; Huizing M
Biomark Med; 2014; 8(5):641-52. PubMed ID: 25123033
[TBL] [Abstract][Full Text] [Related]
51. Major differences in glycosylation and fucosyltransferase expression in low-grade versus high-grade bladder cancer cell lines.
Ezeabikwa B; Mondal N; Antonopoulos A; Haslam SM; Matsumoto Y; Martin-Caraballo M; Lehoux S; Mandalasi M; Ishaque A; Heimburg-Molinaro J; Cummings RD; Nyame AK
Glycobiology; 2021 Dec; 31(11):1444-1463. PubMed ID: 34350945
[TBL] [Abstract][Full Text] [Related]
52. O-glycosylation of α-1-acid glycoprotein of human milk is lactation stage related.
Orczyk-Pawiłowicz M; Berghausen-Mazur M; Hirnle L; Kątnik-Prastowska I
Breastfeed Med; 2015 Jun; 10(5):270-6. PubMed ID: 26057552
[TBL] [Abstract][Full Text] [Related]
53.
Pirro M; Mohammed Y; van Vliet SJ; Rombouts Y; Sciacca A; de Ru AH; Janssen GMC; Tjokrodirijo RTN; Wuhrer M; van Veelen PA; Hensbergen PJ
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752259
[TBL] [Abstract][Full Text] [Related]
54. Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer.
Kobayashi H; Terao T; Kawashima Y
J Clin Oncol; 1992 Jan; 10(1):95-101. PubMed ID: 1727929
[TBL] [Abstract][Full Text] [Related]
55. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum.
Zhao J; Simeone DM; Heidt D; Anderson MA; Lubman DM
J Proteome Res; 2006 Jul; 5(7):1792-802. PubMed ID: 16823988
[TBL] [Abstract][Full Text] [Related]
56. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the N- and O-glycoproteome.
Thaysen-Andersen M; Packer NH
Biochim Biophys Acta; 2014 Sep; 1844(9):1437-52. PubMed ID: 24830338
[TBL] [Abstract][Full Text] [Related]
57. Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration.
Julien S; Lagadec C; Krzewinski-Recchi MA; Courtand G; Le Bourhis X; Delannoy P
Breast Cancer Res Treat; 2005 Mar; 90(1):77-84. PubMed ID: 15770530
[TBL] [Abstract][Full Text] [Related]
58. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
[TBL] [Abstract][Full Text] [Related]
59. Glycoproteomics Landscape of Asymptomatic and Symptomatic Human Alzheimer's Disease Brain.
Suttapitugsakul S; Stavenhagen K; Donskaya S; Bennett DA; Mealer RG; Seyfried NT; Cummings RD
Mol Cell Proteomics; 2022 Dec; 21(12):100433. PubMed ID: 36309312
[TBL] [Abstract][Full Text] [Related]
60. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
